EGFR-T790M is a secondary point mutation on exon 20 that replaces methionine for threonine at the amino acid position 790 on the EGFR tyrosine kinase [5] and is present in more than half of NSCLC patients [6]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.